Croda and AAHI partner to drive innovation in vaccine development
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
The average time of dilation lasts three to eight hours
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
Subscribe To Our Newsletter & Stay Updated